# OnCo record bispecific-plus-adc-lymphoma (pairing). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/pairings/bispecific-plus-adc-lymphoma/>
  a schema:MedicalTherapy ;
  onco:kind "pairing" ;
  schema:identifier "bispecific-plus-adc-lymphoma" ;
  schema:name "CD20 bispecific + CD79b ADC (mosunetuzumab + polatuzumab)"@en ;
  schema:description "Pairing a CD20 bispecific with a CD79b ADC lets two targeted drugs with different mechanisms replace chemotherapy in relapsed lymphoma."@en ;
  schema:url <https://onco.cc/pairings/bispecific-plus-adc-lymphoma/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05171647> ;
  onco:cancers <https://onco.cc/cancers/dlbcl/> ;
  onco:trials <https://onco.cc/trials/sunmo/> ;
  onco:pairs <https://onco.cc/drugs/mosunetuzumab/>, <https://onco.cc/drugs/polatuzumab-vedotin/> .
